(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELLFUSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CELLFUSE

ST13

US500000088245691

Class

10

Filing

88245691

Registration

6120774

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

08/05/2025

Trademark type

Word

Nice classes

10

Filing date

12/31/2018

Registration date

08/04/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/04/2020

Last transaction

08/05/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

08/01/2019

First use in commerce

10/01/2019

Drawing code

4

Owner type

16

Owner location

CENTER VALLEY, PA

Examiner

FAUCETTE,MAX CLIFFORD STE

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

STEM GENIX SOLUTIONS LLC
Regenacell Therapy, Inc.

Representatives

Arvid von Taube RICH MAY, P.C.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical devicesdevices to aspirate bone marrow and harvest autologous bone dowels; synthetic bone graft substitute materials; medical apparatus for the delivery of the combination of bone marrowautologous bone dowels and bone graft material to the surgical site; medical device pack consisting of a combination of medical devices and materialsdevices to aspirate bone marrow and harvest autologous bone dowelssynthetic bone graft substitute materialsmedical apparatus for the delivery of the combination of bone marrowautologous bone dowels and bone graft material to the surgical site

Publications

History of USPTO decisions and trademark events.

26 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/04/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/20/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

08/04/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/01/2020

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

06/25/2020

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

06/24/2020

IUAA

USE AMENDMENT ACCEPTED

06/24/2020

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

06/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/17/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/17/2020

ALIE

ASSIGNED TO LIE

03/16/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/09/2020

IUAF

USE AMENDMENT FILED

03/06/2020

EAAU

TEAS AMENDMENT OF USE RECEIVED

03/06/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/11/2019

GNFR

FINAL REFUSAL E-MAILED

09/11/2019

CNFR

FINAL REFUSAL WRITTEN

09/11/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/20/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/19/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/19/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/25/2019

GNRT

NON-FINAL ACTION E-MAILED

04/25/2019

CNRT

NON-FINAL ACTION WRITTEN

04/25/2019

DOCK

ASSIGNED TO EXAMINER

03/20/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/22/2019

NWAP

NEW APPLICATION ENTERED

01/03/2019

Continuous trademark protection

Get notified about every new filing that threatens CELLFUSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.